<code id='48B5D69716'></code><style id='48B5D69716'></style>
    • <acronym id='48B5D69716'></acronym>
      <center id='48B5D69716'><center id='48B5D69716'><tfoot id='48B5D69716'></tfoot></center><abbr id='48B5D69716'><dir id='48B5D69716'><tfoot id='48B5D69716'></tfoot><noframes id='48B5D69716'>

    • <optgroup id='48B5D69716'><strike id='48B5D69716'><sup id='48B5D69716'></sup></strike><code id='48B5D69716'></code></optgroup>
        1. <b id='48B5D69716'><label id='48B5D69716'><select id='48B5D69716'><dt id='48B5D69716'><span id='48B5D69716'></span></dt></select></label></b><u id='48B5D69716'></u>
          <i id='48B5D69716'><strike id='48B5D69716'><tt id='48B5D69716'><pre id='48B5D69716'></pre></tt></strike></i>

          focus

          focus

          author:fashion    Page View:9
          Robert F. Kennedy Jr.
          Robert F. Kennedy Jr. arrives in the lobby of Trump Tower in New York for a meeting with President-elect Donald Trump. Evan Vucci/AP

          WASHINGTON — Outspoken vaccine critic Robert Kennedy Jr. said Tuesday that he had accepted a position in Donald Trump’s administration as chair of a panel on vaccine safety and scientific integrity, in what would be the clearest sign yet of the president-elect’s suspicions about vaccines.

          Kennedy’s remarks followed his meeting with the president-elect at Trump Tower and immediately sparked outrage from scientists, pediatricians, and public health experts, who fear the incoming administration could give legitimacy to skeptics of childhood immunizations despite a huge body of scientific research demonstrating that vaccines are safe. Many of those skeptics believe vaccines are a cause of autism.

          advertisement

          Hours later, Trump spokeswoman Hope Hicks said in a statement that the president-elect was “exploring the possibility of forming a commission on Autism,” but said “no decisions have been made at this time.”

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more
          FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy
          FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

          PeterMarks,theFDA'stopregulatorofgenetherapies(right),speakswithSTAT'sAdamFeuersteininSanFrancisco.S

          read more
          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more

          Neuroscience startup Neumora files for IPO

          MarioTama/GettyImagesNeumora,aneurosciencestartupfoundedbyVCArchVenturePartners,hopestobecomeoneofth